Candida spe cies ar e commo n inhabitants of the oral cav ity of patients with saliva ry gland dysfunction. The purpose of this study wa s to det ermine the prevalence and density oforal Candida albican s in patient s with Sjogren 's syndro me, to assess the infectious age nt' s oral manifestations and to compare the number of co lony -f orming units (CFU) of C. albican s in patients with primary (n=9) and secondary Sj ogr en's (n =18) with the who le unstimulated saliva ry fl ow rate in each group. An ageand sex -matche d group of cont rol subjects (n=14) wa s se lected for comparison .
compromising conditions or in those with other alterations in the human host defen ses, Candida may proliferate to abnormally high levels.':'
The literature indicates a particularly high rate of e. albican s colonization in individual s with salivary gland dysfunction.>'? In most of these studies, Candida infection levels appear to be inversely related to salivary flow. Certain studies also demon strate an incre ased quantity of e. albi cans in the oral flora of patients with Sjogren's syndrorne.!':"
Saliva has many constituents that have potent antifungal properti es, such as the histati ns; thus, it plays an important role in host defen se and protecti on from yeasts such as Candida species .P:'"Patients who have reduced salivary flow caused by Sjogren' s syndrome, rad iation therapy and anticholinergic drug use have been reported to have a high prev alence of oral e. albicans infectio ns.v"!' :" Aside from xeros tomia, one of the most frequent complai nts of these patients is glossodynia, which also has been highly associated with e. albicans infections.P'v":" Sjogren' s syndrome is an auto immune disease comp lex that is characterized by a triad of clinical conditions: keratoconjunctivitis sicca , xero stomi a and a connective tissue disease (usually rheumatoid arthriti s). Primary Sjogren ' s clinically manife sts as only keratoconjunctivitis sicca and xero stomia, wher eas secondary Sjogren' s manifests as either keratoconjunctiviti s sicca or xero stomia and a systemic connective tissue disease. 14.18·20 .The syndrome is a benign lympho sial adenopath y that, histologically, appe ars as an autoimmune lymphocytic infiltration of the salivary glands . Oral manifestations typically include hypo salivation, glossitis, mucositi s, angular cheilosis and an increased dent al caries rate. 14.18.21 The purpose of this study was to assess and to compare the prevalence and density of e. albicans, using quantitative cultures, in patients with primary and seco ndary Sjogren 's syndrome and to identify the oral manifesta-RHODUS, BLOOMQUIST, L1LJEMARK, BEREUT ER tions of infection with respect to salivary flow rates and quantities of C. albicans. The novel feature of this study design is the correlation of C. albicans quantities with low salivary flow rates .
Methods
Twenty-seven patients with definitively diagnosed Sjogren's syndrome (nine with primary and 18 with secondary) were enrolled in this study. They were compared with 14 healthy, age-and sex-matched control patients who had normal salivary flow (>0.4 ml/min). All subjects were from the University of Minnesota Oral Medicine Clinic. With the approval of the Committee for the Use of Human Subjects in Research at the University of Minnesota, informed consent was obtained from all subjects. Inclusion criteria for the selection of the xerostomia subjects included definitive diagnosis ofprimary or secondary Sjogren's syndrome according to the San Diego criteria (i.e., signs and symptoms of ocular dryness, Schirmer's test [<8 mm l5 min], positive rose bengal corneal staining, plus ANA serologic profi les> 1:160 or rheumatoid factor> 1:160 or labial salivary gland histology : focus score >2 based on >4 lobules, or the presence of anti-SS -A [Ro] or anti-SS-B [La antibodies], 30 years of age or older and salivary flow less than 0.20 ml/m in whole unstimulated saliva) ( Table 1) . 10, 14, 19 The drugs and dosages that each of the patients was taking were carefully documented. Individuals taking drugs that induce hyposalivation, such as anticho linergics , antihistamines, antihypertensives, and beta-adrenergic blockers, were excluded from the study . Subjects who were taking antifungal or antibiotic agents were excluded from the study as well." Therefore, the control subjects had no significant medical diagnoses, were not on drugs that induce hyposalivation and did not use tobacco in any form.
All subjects who had met enrollment diagnostic criteria received a thoro ugh oral exam ination by an experienced clin ical investigator and completed a questionnaire that evaluated specific symptoms of their xerostomia." Each subject then underwent sialometric evaluation. Who le unstimulated and parotid stimulated saliva were collected between 9 AM and 11AM using appropriate techniques.20.23
To obtain unstimulated whole saliva, the clinicians asked patients to first swallow, then to continue expectorating all saliva into a 10-ml test tube for five minutes without swallowing. After a brief rest period, stimu lated parotid saliva was then collected with modified Carlson-Crittenden cups connected with calibrated Tygon tubing marked off in four 0.5-ml increments and placed over the papilla of Stensen' s duct on the righ t side of the patient's mouth. A drop of2% citric acid was placed on the bilateral dorsal surfaces of the tongue every 30 seconds to stimulate parotid saliva flow . Stimu lated saliva was allowed to 48 drain from the attached tubing into a marked test tube for precisely two minutes and was discarded. Saliva was then collected for an additional three minutes . The final volume and flow rate of parotid saliva was determined gra vimetrically. 23, 24 An experienced clinician exam ined the oral cavity of each subject to determine whether mucosa l lesions related to C. albicans infection were present. Detected lesions were identified and categorized into the four types outlined by Hernandez and Daniels: 15 1) pseudomembranous white plaques, 2) eryt hematous cand idiasis, 3) angular chei litis, and 4) hyperplastic white plaq ues. An anaerobic culture swab was then passed over the dorsal portion of the tongue and across the soft palate of each Sjogren's subject and immediately returned to its container. 15Within 30 minutes of collection, the swabs were taken to the laboratory for plating . They were vortexed in 1 ml of Todd-Hewitt broth for one minute and then serially plated in duplicate on selective streptomycin-vancomycin media in 1110 diluted Todd-Hewitt broth for the isolation of C. albicans." The cultures, which consisted of trypicasesoy agar (BBL) with 2 mg% streptomycin and 0.75 mg% vancomycin, were incubated aerobically at 37" C for 48 hours . The numbers of colony-forming units (CFU) Iml of C. albicans were then counted. Please see briefsummaryofPrescribing Inl ormation on adjacentpageofthisadvertisement population. Therefore. theoDhylline levels should be closely monitoredandappropriate dosage adjustments madewhen levolloxacin is co-acmlnls terec, Adverse reac tions. inCluding seizures, mayoccur with or withoutan elevation in serum theO Dhylhne levels.
(See WARNINGSand PRECAUTIONS: uenerau Wa rfarin : flo significant effect 01 levotlcxacin on Ihe peak plasma concentrations, AUC. and other disposition parameters for R-andS·warfarinwasdetectedinadimcat study involving healthyvolunteers. Nosignificant change inprothrombintimewasnotedinthe presence of levolloxacin. Similarly. no apparent ertect of wartann on levolloxacinabsorption anddisposition wasobserved. However. since someQuinolones have been reported to enhance theenects 01oral anticoagulantwarf arinor its derivatives in thepatientpopul ation. the prothrombintimeorother suitablecoag ulation testshould beclose ly mon itored il a quinolone antimicrobi al is administer edconc omitantly withwarfarinor itsderivatives.
Cydospori ne:tJosignificanl ertect oflevofioxa cinonthepeak plasmaconcentr ations.AUC.andotherdisposition parameterslor cyclosparine was detected ina dinicalstudyinVOlvinghealthy volunteers. However. elevatedseru m levels 01 cycIosporine have been reoct edin the patientpopulation when co-administeredwithsome otherQ uinol ones.Levolloxaci nCm1.O and~wereslightlylowe r whileTmil and t l12 were slightly longer in thepresence of cydosporine than those observed in other stud ies withOut concomitantme dication. The dlflerences, however. are not consider edtobe Cl inica lly signi llcantTherefore. nodosage adjustment is requiredforlevofloxac in Ol" cycIospOrinewhen administeredconcomitantl y. Digoxin; tlo significant effect of levotlcxacin onthe peak plasma concentrations, AUC. andother disposi tionparameters tor digoxin was detected ina dinicalstudyinvolving hea lthy volunteers. l evofioxacin absorptionand disposition kinetics weresimilar in thepresence or absence ofdigox in.Therefore. nodosa geadjust ment forlevotcxacin ordigoxinisrequiredwhen administe redconcomitantly. Pr obenecidandCimetidine:flosign ificant ellectofprobenecidorcimetcme ontherateandextent cnesonoxacn absorption wasot:lserved ina dinicalstudy involvi ng healthyvolunteers.TheAUCandt 1l 2 oflevolloxacinwere 27-38%and30%higher, respectively. whileCUF and C41 were 21-35% lower during concomitant treatment with prO benecid or cimetidine comparedto levofloxacin alone. Although these dlfler ences werestatist icallysi gni fican t thechangeswerenothighenoughtowarrant dosageadj ustment for levo floxac inwhe nprObenecid orcimet idineisco·administered. rlon-steroi dal anti-infl ammatory drugs: Theconcomitant administrationof a non-steroidal anti-inflammalory drugwi th a quinolcne.
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tevoncxacin caused no impairment of fertility or reproductive perf ormance in rats at oral doses as high as 360 mg/kg/day (2124mgJm"),correspondingto3.0or18 times therecommendedmaximumhumandosebased onsurla ceareaorbody weight. respectively, andintravenousdoses ashi ghas100mglkglday(590mglm"), corresponding to1.0 or5 times therecommended maximumhuman dose based onsurfacearea orbody wei ght, respectively. Pregnancy:Teratogeni c Etfects, Pregnancy Cat egoryC. Levofl oxacin wasnot teratogenic in rats at ora l doses ashigh as810 mgtkglday (4779mgf m").whichcorresponds to 14or 82times the recommendedmaximumhuma ndosebased onsurface areaorbody weight respectively. oratintravenousdoses ashighas160mgtkglday (944 mgfm")correspondilV:lto 2.7or 16 times lherecommendedmaximumhumandosebased onsurface areaorbody weight respectively. Oases equivalentlo 26or81timesthe recommended maximum humandose ol levofloxaci n (based onsurface areaor body weight respectively) causeddecreased fetalbody weightandincreased letal mortalityin ratswhe nadministere dora llyal 810mgtkgfday 18910mgtm" subjects ( 14%) had the "typical" pseudomembranous form of candidiasis (Fig ure 2, C) . No ne of the Sjogren's subjects had hyperplastic white plaques, and none in the con tro l gro up had oral lesions.
Controls

Subject Groups
Primary and Second ary Sjogren's
Oral Manifestation
Erythematous candidiasis 63% 0 (EC) Angular cheilitis (AC) 48%* 0 Pseudomembranou s cand idiasis (PC) 14% 0
Hyperplastic candidiasis (HC) 0% 0
Total 81%** 0 "'Also pre sented with EC or PC ':''''Adju sting for overlapping conditions 
Results
The mean age of all study subjects was 56.3 years, ranging from 37 to 79 years ( Table 2 ) . All nine of the subjects with primary Sjogren 's were fe male, but only one of the 17 secondary syndrome su bjects was female; 13 of the 14 co ntro l subjects were female. No ne of the subjects wore dentures.
The mean whole unstimula ted sali- In every case, positive Candida cultures were accompanied by some form of cli nical ma nifes tation ( (Figure 2, A) , followed by angular che ilitis (13/27 or 48 %) (Fig ure 2, B) . Some overlap occ urred; six subjects had both eryt hematous candidiasis and angular cheilitis. Only two Volume 78, Number 1 RHODU S. BLOOMQUI ST. L1LJEMAR K. BEREUTER
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Discussion
Numerou s studies have shown that Candida spec ies are presen t in health y dentat e ad ults with normal salivary glan d fun cti on . In fac t, several studies have demon str ated that as man y as 40 % of healthy dentat e ind ivi dua ls h ave pos itive C. albicans co unts .l-' In other studi es, the ran ge varies con sid erabl y: M acFarlane and Sam aramayake have rep orted ra tes of up to 71 % in th is population, " whereas Ar endorf and W alk er i found very low qu antiti es of C. albicans and a prevalen ce of 17% in normal, healthy dentate adults . W right, Cl ark and Hardie? rep orted a 34 % prevalen ce in a similar co ntro l gro up and also found the qu antities of C. albican s to be very lo w (CFU-40) . Altho ugh the subjects in that parti cular study we re denture wearers , many subjects have dem on strat ed po si- Th e present study revealed not only positi ve C. albi cans cul tures in mo st of the research subj ec ts but also showed ex tre me ly high numbers of C. albi cans in the pat ient s with hyp osa1ivati on ca use d by eithe r pr im ary or secondary Sj ogren ' s sy ndrome. Scope: The mee ting is des igned to add ress some of the more com mon probl em s wh ich a re encou ntered in the prac tice of otolary ngolog y. T he subj ect material will include top ics in alle rgic rhinitis, otitis media , foreign bodi es, Weg en er' s disease, skull base surge ry, orbital decompression & recon struction , cance r prevention , surgical onco logy, Zenker 's diverticulum , thyroplastic theory & practice , ch emo therapeutic age nts in oral infections , th e agin g upper face, Boto x use, leech therap y in plastic surgery, acute post-op pain management, anest hesia techniques, tripod fract ures , thyroid ma lignancies , ve lophary nx VPI , VPS probl em s. X-ray case studies and clinicopa thologic correlations .
Objective & Faculty: The course objective is to refresh the participants' knowledge of the var ious aspects of th e field of otolaryngology and the fields of close ly asso ciated specialties whic h can be applie d to the practice of the specially. This wil l include discussions of new conce pts , chan ging c linical presentat ions, avoid an ce of clinical comp lication s and recogniti on of ser ious or critica l co nd itions . A wide range of exp eri en ced and kno wledg eabl e Uni versity of Nebraska Coll eg e of Medi cine faculty along with outstanding gu est faculty will present their top ics during th e dail y 7-9:30 am and 4:30-6:30 pm ses sions. For more information Circle 114 on Reader Service Card RHO DUS, BLOOMQ UIST, L1 LJEMARK, BER EUT ER systemic inflammatory conditio n. Furthermore, all of the Sjogren's subjects ex hibited very low whole unstimulated salivary flow rates (i.e., <0.07 ml/min).
Contrary to other study findings, none of the control subjects in this study had cultivable C. albicans. Although a clear explanation for thi s finding is elusive, one possible factor migh t be the very hea lthy dental status of the control subj ects. Th ey were all dental health care workers, nonsmokers , completely dentate and medication free .
Additionally , this study showed that C. albicans co lonization was sig nificantly gre ater in secondary Sjogren's syndrome subjects than in primary syndrome subjects. This may be att ributed, in part, to the presence of an inflammatory disease in secondary Sjogren 's as well as to the low salivary flow rates in this gro up.
Of the Sjogren's syndrome subjects in this study, 8 1% presented with bo th po sitive cultures for C. albi cans and some form of clinical man ifestation of the infection. Most of the Sjogren's subjects who had significant C. albicans counts (>200,000 CFUs) also had very low salivary flow (i.e., <0 .04 mllmin , n = 12/14 or 86 %); however, there did no t seem to be a direct-linear rel ationship with who le unstimul ated salivary flow rate . Those 14 Sjogren's subjects had very low who le unstimulated salivary flow (x = 0.033 ml/min). T wo of those subjects, however, had negative cult ure resu lts for C. albi cans . The reason for th is finding is difficult to explain.
Additionally , six Sjogren' s syndrome subjects had very hig h C. albicans counts, but the ir whole unstimu lated salivary flow rate was hig her when compared with other Sjogren's subj ects. A few of the Sjogren 's subj ects with the lowest flow rates did not demonstrate the highest numbers of C. albi cans and vice versa.
Erythematous candidi asis was the most common lesion de tected (63 %) during the oral examination of subjects with C. albicans infection. Thi s finding sup ports tha t of a similar study by Hernandez and Daniels. 15 Angular cheilitis was also common (48 %), but most often it accompanied ot her forms of candidiasis . The classic white, pseudomembranous plaq ues of C. albi cans were no t commonly observed (14 %), and , in every case, it was accompanied by ang ular cheilitis.
In this study, all case s of chronic atrophic candidiasis or ang ular chei litis lesions man ifested in subjects who had high C. albicans counts (x CFU /ml = 2.7 x 10 6 ) . In the study by Navazesh et al' ? most of the su bjects did not present with clinical signs of candidiasis, although those who did ex hib ited the highest C. albicans counts (>500 CFU). In that study, the highest Candida count was 38.83 x 10 3 CFU/sc; however, the C. albicans counts in the present study were subs tant ially higher ( Table 2 ). In addition , a higher percentage of the subj ects in this study presented with oral man ifestations than in the Navazesh study. Perhaps this was because of ot her contributing 52 factors, such as immunologic status, of the study pop ulation .
On ly five Sjogren's syndrome subjects in this study had no clin ica l manifestations of Candida infection and , as expected, their culture results also were negative. Those five subj ects (one with primary and four wit h secondary Sjogren' s) had mean whole unstimulated salivary flow rates higher than the mean rates of the subjects with the highest amount of Candida (0.033 ml/min) in the Navazesh et al study . 10 Th e present study confirms and extends the findings of previous investigations. A lthough there appears to be a positive correlation between diminished who le salivary flow and the coloniza tion of C. albicans, there does not appear to be a linear association between the amount of C. albi cans and salivary flow after a certain point of very low flow rates. In add ition, C. albicans colonization was fo und to be greater in secondary Sjogren 's syndro me patients than in primary syndrome pat ients, and the most common clin ica l ma nifestation of C. albi cans colonization was erythematous candidiasis.
The exp lanation for these ob servations is not clear. Furt he r investigations are necessary to provide further insight into the precise re lat ion ship between diminished salivary flow and C. albi cans infection or colonization .
